3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thromboembolism
3
Neoplasms
3
Venous Thrombosis
2
Thromboembolism
2
Pulmonary Embolism
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Vascular Diseases
1
Urogenital Neoplasms
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
padeliporfin
4
motexafin gadolinium
2
Sunitinib
2
Radiotherapy
2
Paclitaxel
2
Genetic Testing
2
Carboplatin
2
vinflunine
1
temsirolimus
1
sipuleucel-T
1
niraparib
1
luprolide acetate gel depot
1
apalutamide
1
Tinzaparin
1
Therapeutics
1
Taste
1
Surveys and Questionnaires
1
Specimen Handling
1
Sildenafil Citrate
1
Remote Patient Monitoring
1
Radiation Dose Hypofractionation
1
Pemetrexed
1
Ocoxin
1
Neoadjuvant Therapy
1
Leuprolide
1
Immunotherapy
1
Imatinib Mesylate
1
Imagery, Psychotherapy
1
Genetic Counseling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urogenital Neoplasms
×
Tinzaparin
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled